Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hantech Bio-Technology CoROCO:1294 +1.25%70 ROA % is 14.48% as of Mar. 2026, which is 19% above its 10-year median of 12.17. GuruFocus rates ROCO:1294 with a GF Score™ of 70/100 and a GF Value™ of NT$80.58 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 1,993 Consumer Packaged Goods companies, Hantech Bio-Technology Co ranks better than 89.21% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Hantech Bio-Technology Co's annualizedNet Income for the quarter that ended in Mar. 2026 was NT$170.9 Mil.
Hantech Bio-Technology Co's average Total Assets over the quarter that ended in Mar. 2026 was NT$1,180.0 Mil. Therefore, Hantech Bio-Technology Co's annualized ROA % for the quarter that ended in Mar. 2026 was 14.48%.
The historical rank and industry rank for Hantech Bio-Technology Co's ROA % or its related term are showing as below:
ROCO:1294'
s ROA % Range Over the Past 10 Years
Min: 6.33 Med: 12.17 Max: 25.59
Current: 12.89
During the past 7 years, Hantech Bio-Technology Co's highest ROA % was 25.59%. The lowest was 6.33%. And the median was 12.17%.
ROCO:1294's ROA % is ranked better than 89.21% of 1993
companies
in the Consumer Packaged Goods industry
Industry Median: 3.34
vs ROCO:1294: 12.89
Hantech Bio-Technology Co (ROCO:1294) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Hantech Bio-Technology Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hantech Bio-Technology Co ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Hantech Bio-Technology Co's ROA % distribution charts can be found below:
* The bar in red indicates where Hantech Bio-Technology Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Hantech Bio-Technology Co (ROCO:1294) has a ROA % of 14.48% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Hantech Bio-Technology Co and its competitors. This is 19% above median its historical median of 12.17. Over the past decade, Hantech Bio-Technology Co's ROA % has ranged from 6.33 to 25.59. According to the industry distribution chart, Hantech Bio-Technology Co ranks #215 out of 1993 companies in the Consumer Packaged Goods industry, placing it in the top 10.8%.
Is Hantech Bio-Technology Co's ROA % too high?
Hantech Bio-Technology Co's current ROA % of 14.48% is 19% above median its 10-year median of 12.17. Over the past 10 years, this metric has ranged from a low of 6.33 to a high of 25.59. The Consumer Packaged Goods industry median ROA % is 3.34. Hantech Bio-Technology Co's value of 14.48% is 333.5% above this industry median. Based on the distribution chart, Hantech Bio-Technology Co ranks #215 out of 1993 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Hantech Bio-Technology Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hantech Bio-Technology Co's ROA % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hantech Bio-Technology Co ranks #215 out of 1993 companies for ROA %. This places Hantech Bio-Technology Co in the top 11% of its industry — outperforming the majority of peers. The industry median ROA % is 3.34. Hantech Bio-Technology Co's value of 14.48% is 333.5% above this benchmark. Historically, Hantech Bio-Technology Co's own ROA % has ranged from 6.33 to 25.59 over the past decade. While the company's 10-year median is 12.17 vs. the industry median of 3.34, Hantech Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.34, based on 1,993 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hantech Bio-Technology Co's current ROA % of 14.48% is 333.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Hantech Bio-Technology Co and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hantech Bio-Technology Co's current ROA % is 14.48%, which is 19% above median its own 10-year median of 12.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hantech Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Hantech Bio-Technology Co (ROCO:1294) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$80.58, compared to a current price of NT$56.80 — trading 29.5% below its estimated fair value. The current ROA % is 14.48%, which is 19% above median its 10-year median of 12.17 and 333.5% above the Consumer Packaged Goods industry median of 3.34. Hantech Bio-Technology Co's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Hantech Bio-Technology Co (ROCO:1294), the current ROA % is 14.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hantech Bio-Technology Co (ROCO:1294) Overvalued in 2026?
Based on GuruFocus' analysis, Hantech Bio-Technology Co stock appears to be undervalued.
The current stock price of NT$56.80 is trading 29.5% below its estimated GF Value™ of NT$80.58.
GuruFocus considers Hantech Bio-Technology Co to be Significantly Undervalued.
Key valuation signals for ROCO:1294:
ROA %: 14.48% (19% above median its 10-year median of 12.17)
GF Value™: NT$80.58 vs. price of NT$56.80 (29.5% below fair value)
Industry Position: 333.5% above the Consumer Packaged Goods median (#215 of 1993)
No single metric tells the full story. See the ROCO:1294 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hantech Bio-Technology Co Ltd mainly engaged in the manufacture, trading, and agency of biotech foods, health foods, and Traditional Chinese Medicine skincare and beauty products.
70GF Score
Get the complete analysis for ROCO:1294
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1294 has been successfully added to your 
